Parkman Healthcare Partners’s Liquidia Corp LQDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-101,767
Closed -$1.22M 110
2023
Q4
$1.22M Sell
101,767
-15,486
-13% -$111K 0.17% 78
2023
Q3
$743K Sell
117,253
-163,881
-58% -$1.18M 0.14% 94
2023
Q2
$2.21M Sell
281,134
-45,831
-14% -$356K 0.38% 72
2023
Q1
$2.26M Buy
326,965
+57,773
+21% +$394K 0.49% 55
2022
Q4
$1.71M Buy
269,192
+14,740
+6% +$79.2K 0.46% 60
2022
Q3
$1.38M Buy
+254,452
New +$1.43M 0.39% 67

Other funds holding LQDA

Parkman Healthcare Partners's LQDA Position: Q1 2024 in Review

Parkman Healthcare Partners sold out of Liquidia Corp (LQDA) in Q1 2024, closing a stake of 101,767 shares — an estimated $1.22M sold.

Parkman Healthcare Partners first reported a position in LQDA in Q3 2022 and held it in 6 quarters. The position peaked at $2.26M in Q1 2023. 140 funds tracked by Wall St. Rank hold LQDA as of Q1 2024.

  • Parkman Healthcare Partners reported no remaining Liquidia Corp position as of Q1 2024 after selling out during the quarter.
  • Parkman Healthcare Partners sold 101,767 Liquidia Corp shares in Q1 2024, an estimated $1.22M.
  • Parkman Healthcare Partners first reported a position in Liquidia Corp in Q3 2022 and held it in 6 quarters.
  • Parkman Healthcare Partners's Liquidia Corp position peaked at $2.26M in Q1 2023.
  • 140 funds tracked by Wall St. Rank held Liquidia Corp as of Q1 2024.

Based on Parkman Healthcare Partners's 13F filing for Q1 2024, filed 15 May 2024.